ANGELA FARRELL: Open Payments
NPI 1497273544 · MURRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 16 payments from 12 companies in 2025. Trend: 2023 $798 · 2024 $635 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| Dexcom, Inc. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Amgen Inc. | 2 | $29 |
| Lilly USA, LLC | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: LEQVIO, Dexcom G6 Transmitter, Kerendia, OTEZLA, MOUNJARO, TEFLARO, ENTRESTO, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
